SEC Comment Letter for Enveric Biosciences, Inc. (ENVB) (CIK 0000890821) (ENVB) — Nov 20, 2018
Enveric Biosciences, Inc. (ENVB) (CIK 0000890821)
Date: Nov. 20, 2018 · CIK: 0000890821 · Accession: 0000000000-18-035898
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-228354
Letter
November 20, 2018 Brent Kelton Chief Executive Officer AMERI Holdings, Inc. 5000 Research Court, Suite 750 Suwanee, Georgia 30024 Re:AMERI Holdings, Inc. Registration Statement on Form S-1 Filed November 13, 2018 File No. 333-228354 Dear Mr. Kelton: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Michael Fay at 202-551-3812 with any questions. Sincerely, Division of Corporation Finance Office of Electronics and Machinery cc: Adam W. Finerman
Show Raw Text
November 20, 2018
Brent Kelton
Chief Executive Officer
AMERI Holdings, Inc.
5000 Research Court, Suite 750
Suwanee, Georgia 30024
Re:AMERI Holdings, Inc.
Registration Statement on Form S-1
Filed November 13, 2018
File No. 333-228354
Dear Mr. Kelton:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Michael Fay at 202-551-3812 with any questions.
Sincerely,
Division of Corporation Finance
Office of Electronics and Machinery
cc: Adam W. Finerman